ESTA Earnings Prediction
The chart below shows how ESTA performed 10 days before and after its earnings report, based on data from the past quarters. Typically, ESTA sees a +10.09% change in stock price 10 days leading up to the earnings, and a +5.33% change 10 days following the report. On the earnings day itself, the stock moves by -2.56%. This data can give you a slight idea of what to expect for the next quarter's release.
ESTA Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
40.23M
4.47%
-8.82%
Gross Margin
63.93%
-5.51%
-2.53%
Operating Margin
-32.66%
-40.23%
54.20%
Net Margin
-41.47%
-45.45%
6.50%
EPS
-0.59
-47.32%
-4.84%
No Data Available
ESTA Earnings Analysis
Establishment Labs Holdings Inc. Corporation (ESTA.O) Earnings Conference Call
Positive
Milestone in Plastic Surgery: The approval of Motiva implants on September 26 was a watershed moment for our company and for the plastic surgery industry.
Exceeded Launch Expectations: The launch has exceeded even our high expectations.
Q3 Revenue Increase: Revenue in the third quarter of 2024 totaled $40.2 million, an increase of 4.5% from the year ago period.
Strong Cash Position: Our cash position at the end of the third quarter was $114 million, allowing us to fully invest in our U.S. growth initiatives.
Registered Direct Offering Announcement: We are announcing that we have completed a registered direct offering to invest $50 million at a 5% discount to our closing price.
Negative
Cash Loss Reduction: Cash loss in 3Q was $14.9 million, down more than 60% from a year ago.
Quarterly Net Loss Comparison: Net loss from operations in the third quarter was $13.1 million compared to a net loss of $21 million in the same period in 2023.
Adjusted EBITDA Loss Reduction: Adjusted EBITDA was a loss of $7 million in the quarter compared to a loss of $16.3 million in the third quarter of last year.
Operating Expenses Increase: Total operating expenses for the third quarter were $38.9 million, an increase of approximately $8.2 million from the year ago period.
Gross Profit Impact Analysis: Our gross profit for the third quarter was impacted by the revaluation of our euro-denominated inventory at quarter end, which had a negative impact on our cost of goods.
ESTA FAQs
How does ESTA typically perform around its earnings report dates?
Is Establishment Labs Holdings Inc. (ESTA) Q3 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
ESTA Earning Call Sentiment
Establishment Labs Holdings Inc. (ESTA) Q3 2024 Earnings Call Transcript
1.0x
00:00
00:00
ESTA.O
2.52%Positive
Basic Financial Performance: 3 - Revenue growth and reduced losses are positive, but a registered direct offering and supply chain issues are concerning.\nProduct Development and Business Update: 3 - Positive FDA approval, but regulatory delays and demand fluctuations are negative.\nMarket Strategy: 3 - Expansion plans are promising, but economic conditions pose risks.\nExpenses and Financial Health: 3 - Decreased expenses are good, but increased operational activity raises concerns.\nShareholder Return Plan: 2 - Registered direct offering at a discount is negative.\nQ&A insights: Analysts showed cautious optimism, but uncertainties remain.\nConsidering market cap, a neutral stock price movement is expected.